8-K
Current Report
Aldeyra Therapeutics, Inc. Filed Acc 0001193125-19-166628
Shareholder vote results · Regulation FD disclosure
- Item 5.07 Submission of matters to a vote of security holders
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading d747171d8k.htm…